Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000233448 | SCV000288581 | benign | Primary familial hypertrophic cardiomyopathy | 2023-12-30 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001092690 | SCV001249317 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | ILK: BP4 |
Gene |
RCV001092690 | SCV001943009 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004020814 | SCV003706064 | likely benign | not specified | 2021-11-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome Diagnostics Laboratory, |
RCV001092690 | SCV001978403 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001092690 | SCV001980046 | likely benign | not provided | no assertion criteria provided | clinical testing |